Cisplatin: Antitumor Pharmacodynamic Profiles, Clinical Utility and Nanoformulation Design

Cisplatin is a first-line platinum-based chemotherapeutic agent that is widely implemented for the clinical management of diverse solid tumors, ranging from testicular and ovarian carcinoma to bladder and lung cancers. Nevertheless, its therapeutic benefits are substantially hampered by dose-limiting adverse effects such as nephrotoxicity and irreversible ototoxicity, as well as frequent intrinsic and acquired tumor multidrug resistance that greatly reduces treatment response. This article first outlines the core physicochemical and pharmacological features of cisplatin and further elaborates on the molecular mechanisms underlying cisplatin-related toxic injuries and multifaceted tumor resistance, including impaired drug uptake via cation transporters, enhanced intracellular detoxification, abnormal DNA damage repair, and the immunosuppressive tumor microenvironment. Moreover, it systematically summarizes recent research advances in formulation optimization and diverse nanovehicle delivery strategies, ranging from platinum(IV) prodrugs, passive- and active-targeted nanocarriers to stimulus-responsive and synergistic co-delivery platforms that can simultaneously load cisplatin and functional adjuvants. Finally, this review explores major translational obstacles in practical clinical application and puts forward prospective future research directions for cisplatin-based antitumor therapy.

Authors

Institutions

Publication Details

Journal
Theoretical and Natural Science
Published
2026-11-17
DOI
https://doi.org/10.54254/2753-8818/2027.mb39130
Primary Topic
Metal complexes synthesis and properties
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cisplatin: Antitumor Pharmacodynamic Profiles, Clinical Utility and Nanoformulation Design

Yuhui Tian
2 links
Theoretical and Natural Science
Metal complexes synthesis and properties
article

Cisplatin: Antitumor Pharmacodynamic Profiles, Clinical Utility and Nanoformulation Design

Yuhui Tian
article en

Abstract

Cisplatin is a first-line platinum-based chemotherapeutic agent that is widely implemented for the clinical management of diverse solid tumors, ranging from testicular and ovarian carcinoma to bladder and lung cancers. Nevertheless, its therapeutic benefits are substantially hampered by dose-limiting adverse effects such as nephrotoxicity and irreversible ototoxicity, as well as frequent intrinsic and acquired tumor multidrug resistance that greatly reduces treatment response. This article first outlines the core physicochemical and pharmacological features of cisplatin and further elaborates on the molecular mechanisms underlying cisplatin-related toxic injuries and multifaceted tumor resistance, including impaired drug uptake via cation transporters, enhanced intracellular detoxification, abnormal DNA damage repair, and the immunosuppressive tumor microenvironment. Moreover, it systematically summarizes recent research advances in formulation optimization and diverse nanovehicle delivery strategies, ranging from platinum(IV) prodrugs, passive- and active-targeted nanocarriers to stimulus-responsive and synergistic co-delivery platforms that can simultaneously load cisplatin and functional adjuvants. Finally, this review explores major translational obstacles in practical clinical application and puts forward prospective future research directions for cisplatin-based antitumor therapy.

Theoretical and Natural ScienceVol. 202(1)
The Affiliated High School of Peking University (CN)
Good health and well-being
Metal complexes synthesis and properties
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon